Co-founder of Cellogen Therapeutics, a biotechnology company based in New Delhi.
Dr. Gaurav Kharya is Co-founder of Cellogen Therapeutics, a biotechnology company based in New Delhi, founded in 2021. Cellogen Therapeutics's most recent disclosed round was a Growth round of ₹20 crore in May 2026.
Cellogen Therapeutics is a Delhi-based cell and gene therapy company founded by clinicians, developing indigenous CAR-T therapies and gene-editing solutions with GMP-compliant manufacturing aimed at making advanced oncology treatment affordable in India.
Previously backed by NATCO Pharma; new capital advances clinical programs and GMP manufacturing toward human trials. Read the story →
Dr. Gaurav Kharya is a Co-founder of Cellogen Therapeutics, a biotechnology company based in New Delhi, founded in 2021.
Cellogen Therapeutics's founders and leadership on record at StartupFox are Dr. Gaurav Kharya and Dr. Tanveer Ahmad.
Cellogen Therapeutics has raised ₹20 crore across 1 disclosed round on record. The latest was a Growth round of ₹20 crore in May 2026, with Kotak Alternate Asset Managers (Kotak Life Sciences Fund I).
Cellogen Therapeutics is headquartered in New Delhi, India.
StartupFox has published 1 story naming Dr. Gaurav Kharya; the most recent is “Cellogen Therapeutics Raises ₹20 Crore From Kotak Alts to Build an Indigenous CAR-T Cell Therapy Supply Chain”.
This profile is compiled by the StartupFox desk from company announcements, regulatory filings and our own reporting. If this is you, you can verify it with LinkedIn and edit it.
